Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated (NYSE: TDG) files a variety of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its aerospace components business, capital structure and governance. This page compiles TransDigm’s SEC filings and pairs them with AI-powered summaries to help readers interpret the information more efficiently.
Investors can use this resource to locate annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically describe TransDigm’s business segments, risk factors, product categories and financial results. For this company, filings often discuss its role as a designer, producer and supplier of highly engineered aircraft components, its organization into segments such as power and control and airframes, and its use of acquisitions and financial leverage as part of its strategy, as reflected in the Polygon description and company disclosures.
Current reports on Form 8-K are particularly important for tracking material events at TransDigm. Recent 8-K filings describe acquisitions such as the Simmonds Precision Products business and a definitive agreement to acquire Stellant Systems, debt offerings and amendments to the company’s credit agreement, special cash dividends funded with new debt and changes in executive leadership and board composition. These documents provide timely details on transactions, financing terms and governance decisions.
This page also offers access to filings related to debt instruments and credit agreements, where TransDigm outlines terms for senior secured notes, senior subordinated notes and term loans, as well as any amendments that reprice or extend these facilities. Where available, insider transaction reports on Form 4 and proxy statements on Schedule 14A can shed light on executive and director share ownership and compensation structures.
Stock Titan’s platform enhances these filings with AI-generated highlights and explanations, helping users quickly identify key sections, understand complex capital structure language and see how new 8-K events connect to prior disclosures. Real-time updates from EDGAR ensure that new TransDigm filings appear promptly, while the AI layer reduces the time needed to parse lengthy documents and track the regulatory record for TDG.
TransDigm Group Inc. insider transaction: A company officer serving as Co‑Chief Operating Officer reported an option exercise and related stock sale. On 12/01/2025, the insider exercised a stock option to acquire 290 shares of TransDigm common stock at an exercise price of $269.42 per share, then on the same date sold 290 shares of common stock at a price of $1,351.06 per share.
After these transactions, the insider directly beneficially owned 1,055 shares of TransDigm common stock and 1,740 stock options. The filing was made as a Form 4 by one reporting person, reflecting routine insider equity activity.
TDG received a Form 144 notice indicating a planned sale of common stock under Rule 144. A holder intends to sell 290 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $394,449.30. The issuer had 56,318,584 common shares outstanding at the time referenced.
The 290 shares to be sold were acquired on 12/01/2025 by exercising stock options from the issuer, paid in cash on the same date. Over the prior three months, 10b5-1 sales for Patrick J. Murphy included 290 common shares on 11/03/2025 for $379,900.00 and 580 common shares on 10/27/2025 for $785,760.80.
TransDigm Group Inc. filed a Form 4 reporting equity transactions by director Kevin Stein through the Fortuna Trust dated June 1, 2018. On 11/28/2025, the trust exercised a stock option for 4,592 shares of TransDigm common stock at an exercise price of $105.88 per share. The option relates to an award originally exercisable from 09/30/2018 and expiring on 04/25/2028, and its exercise price has been adjusted for dividends declared since August 1, 2022.
On the same date, the trust reported sales of TransDigm common stock in three transactions of 2,997, 1,545 and 50 shares at volume-weighted average prices of approximately $1,360.44, $1,361.25 and $1,362.43, respectively, within narrow intraday price ranges. Following these transactions, the Fortuna Trust indirectly held 8,158 shares of TransDigm common stock.
A shareholder affiliated with NYSE: TDG has filed a Form 144 notice covering the planned sale of 4,592 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 6,222,205.92 reported in the notice, compared with 56,318,584 shares outstanding. The seller acquired these 4,592 shares on the same date via a cash exercise of stock options.
The filing also lists a series of prior Rule 10b5-1 plan sales over the past three months by The Fortuna Trust, each disclosing the number of common shares sold and the gross proceeds on specific dates in October and November 2025. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
TransDigm Group Inc. (TDG) director Kevin Stein, through the Fortuna Trust dated June 1, 2018, reported stock option exercises and related share sales. On 11/25/2025, the trust exercised 4,187 stock options at an exercise price of
A selling stockholder of TransDigm Group Inc. (TDG) filed a Form 144 notice to sell 4,187 common shares through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an indicated aggregate market value of $5,592,827.12, while 56,318,584 common shares were shown as outstanding; this is a baseline figure, not the amount being sold. The shares to be sold were acquired on 11/25/2025 by exercising stock options for cash on the same date.
The notice also lists prior Rule 10b5-1 plan sales over the past three months for The Fortuna Trust U/T/A DTD 06/01/2018, including 7,191 shares sold on 10/18/2025 for gross proceeds of $9,791,047.47 and 1,104 shares sold on 11/20/2025 for $1,502,423.47. By signing, the seller represents they are not aware of undisclosed material adverse information about TransDigm’s operations.
TransDigm Group Inc. (TDG)11/21/2025, as shown on this Form 4. The transaction, coded "G" for gift, was at a reported price of $0 per share.
After this transaction, Graff directly owns 1,653 TransDigm common shares. He also reports indirect ownership of 5,096 shares held by The 2012 Carol Ostrow GST Trust created by his spouse for their children, and 7,000 shares held by certain other trusts created for the benefit of their children, for which he serves as trustee.
TransDigm Group (TDG) director Form 4 shows an option exercise and matching share sale by an affiliated trust. On 11/21/2025, the Fortuna Trust dated June 1, 2018 exercised 230 stock options for TransDigm common stock at an exercise price of $105.88 per share and acquired 230 shares. The trust then sold 230 common shares at an average price of $1,360.3096 per share, leaving it with 8,158 shares of indirect beneficial ownership. Following the transaction, the trust continues to hold 64,275 stock options indirectly, with an exercise price of $105.88 and an expiration date of 04/25/2028.
TransDigm Group (TDG) has a Form 144 notice for the potential sale of 230 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of $305,410.10 for these shares and notes that 56,318,584 common shares were outstanding at the time referenced. The 230 shares were acquired on 11/21/2025 by exercising stock options for cash on the same date.
The notice also details recent activity under a Rule 10b5-1 trading plan for The Fortuna Trust, including common stock sales of 1,104 shares on 11/20/2025, 7,191 shares on 11/18/2025, and 700 shares on 10/27/2025, with disclosed gross proceeds for each transaction. The signatory represents that they are not aware of undisclosed material adverse information about the issuer.
TransDigm Group (TDG) director Kevin Stein, reporting through the Fortuna Trust dated June 1, 2018, disclosed an option exercise and related share sales. On 11/20/2025, the trust exercised a stock option for 1,104 shares of common stock at an exercise price of $105.88 per share, originally granted in 2018 and expiring in 2028. The same day, the trust sold 655 shares at an average $1,360.3298, 400 shares at an average $1,361.5239, and 49 shares at an average $1,363.2231, with each sale reported as an average weighted price over a narrow range. After these transactions, the trust beneficially owned 8,158 shares of TransDigm common stock and 64,505 stock options, all reported as indirect ownership through the trust.
FAQ
What is the current stock price of Transdigm Group (TDG)?
What is the market cap of Transdigm Group (TDG)?
